AEZS - Spark Newswire

2 minute read

24 Stocks Moving in Friday’s Pre-Market Session

Today, 5:25 PM

Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 35% to $3.47 in pre-market trading. Vinco Ventures set record date as May 18, 2022 For dividend of shares related to Cryptyde deal. The dividend is expected to be distributed on May 27, 2022.

AEZS

2 minute read

Aeterna Zentaris Abstract Accepted For Presentation At IMMUNOLOGY2022 Annual Event Of the American Association Of Immunologists

By Benzinga Newsdesk

Today, 5:25 PM

Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) ("Aeterna" or the "Company"), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and

AEZS

2 minute read

Aeterna Zentaris Reports Secured New European Patent For Use Of Macimorelin For Diagnosis Of Growth Hormone Deficiency In Adults

By Benzinga Newsdesk

Today, 5:25 PM

– Strengthens intellectual property portfolio for macimorelin and the commercial product Ghryvelin® / Macrilen™ in Europe as the Company plans to pursue even greater protection TORONTO, ONTARIO, April

AEZS

1 minute read

Earnings

AEterna Zentaris: Q4 Earnings Insights

By Benzinga Insights

Today, 5:25 PM

AEterna Zentaris (NASDAQ:AEZS) reported its Q4 earnings results on Tuesday, March 29, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings AEterna Zentaris reported in-line EPS of $-0.02 versus an estimate of $-0.02.

AEZS

1 minute read

Aeterna Zentaris Says Enrollment In Growth Hormone Deficiency Trial To Continue Into 2023

By Vandana Singh

Today, 5:25 PM

Aeterna Zentaris Inc (NASDAQ: AEZS)

AEZS

2 minute read

Aeterna Zentaris Reports Expansion Of The Scope Of Its Existing Research Program With Julius-Maximilians-University Wuerzburg On Development Of COVID, Chlamydia Vaccines

By Benzinga Newsdesk

Today, 5:25 PM

– Research agreement expanded for development of human 3D intestinal tissue models to study Salmonella enterica pathogenesis TORONTO, ONTARIO, March 10, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS)

AEZS